TICKERNERD
Menu
GLASGLASHealthcare · Drug Manufacturers - Specialty & Generic

GLAS Stock Forecast: Glass House Brands, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$10
+5.56% on the day

The 3 Wall Street analysts covering Glass House Brands, Inc. hold a median 12-month price target of $16 — +59.0% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 62 of 100 as at 1 Aug 2026 — in the upper half.

Market cap
$854.7M
Ticker Nerd rank
62 / 100
Median analyst target
$16
Analysts covering
3
Total return, dividends reinvested
1W
−0.6%
1M
−19.5%
YTD
+13.7%
1Y
+81.3%
From 52W high
−25.9%
From 52W low
+89.5%
$5
$14
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

GLAS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Glass House Brands, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
62 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
71
Momentum
70
Quality
69
Accruals
64
Value
58
Issuance
50
Size
48
Revisions
47
Growth
42

Volatility (71): The share price has been relatively steady.

Growth (42): Sales and profits are flat, shrinking, or growing more slowly than they were.

The rank is the raw material. Whether the rules would actually own Glass House Brands, Inc. — and when they’d sell — is the membership.

Wall Street

GLAS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on GLAS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4$6$8$10$12$14$16$18Oct 25Jan 26Apr 26Jul 26GLASHigh $17Median $16Low $16

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $16Median $16High $17

The green dot is the last close — the median target sits +59.0% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
13 July 2026Lake StreetInitiatesBuy$17

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

GLAS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
1
Fundamentals

Glass House Brands, Inc. (GLAS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−26.9×

Cheaper than 97% of US stocks

Price / sales
4.8×

Cheaper than 26% of US stocks

Price / book
10.5×

Cheaper than 9% of US stocks

EV / EBITDA
−97.0×

Cheaper than 96% of US stocks

Growth & margins
Revenue growth (YoY)
−9.6%

Higher than 16% of US stocks

Earnings growth (YoY)
—
Gross margin
34.0%

Higher than 43% of US stocks

Operating margin
−35.4%

Higher than 20% of US stocks

Net margin
−20.7%

Higher than 15% of US stocks

Returns & dividend
Return on equity
−20.4%

Higher than 31% of US stocks

Return on assets
−5.3%

Higher than 31% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

GLAS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelDrug Manufacturers - Specialty & Generic
CompanyMarket capTKN rank
GLASGlass House Brands, Inc.$854.7M
62
IRWDIronwood Pharmaceuticals, Inc.$689.7M
87
ESPREsperion Therapeutics, Inc.$816.7M
—
AMPHAmphastar Pharmaceuticals, Inc.$879.2M
59
TLRYTilray Brands, Inc.$618.4M
19
PCRXPacira Biosciences, Inc.$1.1B
99
COLLCollegium Pharmaceutical, Inc.$1.1B
100
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. GLAS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest GLAS news & analysis

Glass House Brands Retains Former DEA Compliance Executive to Advise on Interstate Commerce and Export Opportunities

GlobeNewsWire · 27 July 2026positive

Glass House Brands has retained Matt Murphy, a former DEA compliance executive, as an advisor on DEA compliance related to interstate commerce and the export of medical cannabis under Schedule III regulatory requirements.

Why it matters — The retention of a former DEA compliance executive signals Glass House Brands is positioning itself to navigate federal regulatory pathways for interstate cannabis commerce and medical cannabis exports.

3 Top Marijuana Stocks For Investors To Know About Before The Next Run

MarijuanaStocks · 24 July 2026neutral

The article discusses what factors investors typically consider when evaluating marijuana stocks, highlighting the importance of experience and understanding the companies operating in the cannabis space.

Why it matters — GLAS watchers would care because the article reflects the ongoing investor interest in the marijuana stock sector, which includes Glass House Brands as a participant.

FAQ

Frequently asked questions about GLAS stock

What is the GLAS stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Glass House Brands, Inc. have a median 12-month price target of $16, with estimates ranging from $16 to $17. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is GLAS stock a buy right now?

Of the 3 analysts covering Glass House Brands, Inc., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Glass House Brands, Inc. 62 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank GLAS?

As at 1 Aug 2026, Glass House Brands, Inc. ranks 62 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (71 of 100).

Will GLAS stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +59.0% from the last close, and Ticker Nerd's factor model ranks Glass House Brands, Inc. 62 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the GLAS stock forecast for 2030?

No analyst covering Glass House Brands, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for GLAS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $16 to $17 over the next 12 months.

How has GLAS stock performed over the past year?

Glass House Brands, Inc. returned +81.3% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Glass House Brands, Inc. do?

Glass House Brands Inc. is a vertically integrated cannabis company focused on cultivating, manufacturing, distributing, and retailing cannabis products in California.

What is the latest news on GLAS?

The most recent item we track (GlobeNewsWire, 27 July 2026): "Glass House Brands Retains Former DEA Compliance Executive to Advise on Interstate Commerce and Export Opportunities". Glass House Brands has retained Matt Murphy, a former DEA compliance executive, as an advisor on DEA compliance related to interstate commerce and the export of medical cannabis under Schedule III regulatory requirements.

Company

About Glass House Brands, Inc.

Glass House Brands Inc. is a vertically integrated cannabis company focused on cultivating, manufacturing, distributing, and retailing cannabis products in California. Glass House Brands operates greenhouse cultivation facilities, a manufacturing site, and retail dispensaries, serving both wholesale and direct-to-consumer channels. Its business spans bulk flower and trim, cannabis-related consumer packaged goods, and branded products sold through its own stores and third-party retailers. The company’s portfolio includes Glass House Farms, PLUS Products, Allswell, Reeform, and Mama Sue Wellness, reflecting a mix of flower, edibles, wellness, and other cannabis categories. Glass House Brands plays a significant role in California’s regulated cannabis market by combining production, branding, and retail under one operating model.

CEO Mr. Kyle D. Kazan · 357 employees · United States · https://glasshousebrands.com